Related Experiment Video
Updated: Apr 19, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
High-risk pregnancy and the rheumatologist
May Ching Soh1, Catherine Nelson-Piercy2
1Division of Women's Health, Women's Health Academic Centre, King's College London, King's Health Partners, London, UK.
Most women with rheumatic diseases can have successful pregnancies with careful planning. This review covers high-risk pregnancies, complications, and treatments for conditions like SLE and RA during pregnancy and breastfeeding.
Area of Science:
- Rheumatology
- Obstetrics
- Immunology
Background:
- Biologic therapies improve rheumatic disease control, enabling more women to attempt pregnancy.
- Rheumatologists play a crucial role in managing rheumatic diseases during pregnancy.
Purpose of the Study:
- To review high-risk pregnancies in women with rheumatic diseases.
- To discuss maternal and fetal complications, treatments, and long-term outcomes.
- To address controversies surrounding biologic use in pregnancy.
Main Methods:
- Literature review focusing on high-risk pregnancies and specific rheumatic conditions.
- Discussion of evidence and controversies regarding treatment options.
- Emphasis on the multidisciplinary team approach.
Main Results:
- Most women with rheumatic diseases can achieve successful pregnancies with proper management.
- Specific risks and complications associated with conditions like SLE, RA, and vasculitides are detailed.
- Evidence and controversies regarding biologic use during pregnancy and breastfeeding are presented.
Conclusions:
- Careful pregnancy planning and multidisciplinary care are essential for successful outcomes.
- Rheumatologists are vital in guiding management throughout pregnancy and postpartum.
- Further research is needed to clarify optimal management strategies, especially concerning biologics.
Related Concept Videos
Rheumatic Heart Disease IV: Nursing Management
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rh Blood Group
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...

